Brenda Dalzell

CEO Olgeta, CCO of FTM II. Medical Receivables Fund company with operational arm in US.

With a globally informed foundation spanning the full spectrum of care — primary, secondary, and tertiary — I bring a uniquely comprehensive perspective to healthcare finance. I hold an advanced diploma in Healthcare Management and served for ten years as a Medical Officer with the U.S. Peace Corps, delivering clinical oversight in diverse, resource-limited settings. Over the past decade, my focus has shifted to a strategic niche: the assessment, valuation, and management of medical receivables. This specialized area of healthcare finance not only generates consistent, risk-adjusted returns but also unlocks liquidity for underserved medical providers — creating both financial yield and measurable social impact.

Together with my husband and business partner, William (Bill) Dalzell — an accomplished international executive with over 15 years of expertise in medical receivables as an alternative asset class — we have successfully launched and scaled multiple ventures. Bill previously co-founded and served as Director of a globally recognized, award-winning investment fund dedicated to healthcare finance. Our combined leadership blends deep operational and clinical insight with proven investment and portfolio management experience across global markets.

Today, I lead educational initiatives, including webinars, with a focus on demystifying purpose-driven investing — particularly for women who seek low-risk, values-aligned financial strategies. I am passionate about expanding access to this underexplored asset class and helping new investors confidently enter the space. Grounded in the belief that profit and purpose can — and should — coexist, our work is guided by a singular mission: Doing Well by Doing Good.

We invest in healthcare outcomes by funding patient care upfront and bridging the cash flow gap for providers awaiting legal case resolutions. Our model addresses a common gap in personal injury cases: while patients need timely medical care, providers often wait months or years for payment tied to legal settlements. We step in to purchase those medical receivables at a discount, giving providers immediate liquidity and allowing patients to access the care they need.

Once the legal case resolves, we negotiate collections — delivering attractive, risk-adjusted returns to our investors. It’s a low-volatility, socially impactful asset class with built-in legal process momentum. Patients heal, providers thrive, and investors do well — a true win–win–win.

We Do Well by Doing Good